Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

US Patent 11253511 · Granted Feb 22, 2022

Estimated economic value: $176,578,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and 2025
c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and 2025
c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and 2025
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof2025
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)2025
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)2025
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)2025
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)2025
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)2025
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)2025
Selective D3 dopamine receptor agonists and methods of their use2024
Selective D3 dopamine receptor agonists and methods of their use2024